Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The next 10Q is due

I'm not convinced that that is guidance as much as it is a restatement of the performance of the company over the few years.

PTSC's share of License Fees before expenses:

FY2005 - MMP Licensing fees $13.1M

FY2006 - MMP Licensing fees $48.9M

FY2007 - MMP Licensing Fees $43.3M

Q12008 - MMP Licensing Fees $11.7M

 

Obviously it bodes well, but I think a responsible CEO will preface a guidance comment with an explanation that it is just that and I think Turley is a responsible CEO.

Share
New Message
Please login to post a reply